Its main ingredient, Guaifenesin, works by thinning mucus in the airways
& Possani, L
93,94,95,96 Advancements in carrier technology and nucleic acid modification techniques have led to significant progress in overcoming these challenges, as exemplified by the first siRNA drug, patisiran (Onpattro), which has been approved for treating hereditary transthyretin-mediated amyloidosis by degrading mRNA encoding transthyretin (TTR)
For example, some ferroptosis-related predictors, targets and models are still at the level of multi-omics sequencing and basic experimental verification
Peroxynitrite, a strong inducer of cell death, can lead to inflammation, vascular diseases, and neurodegeneration [272]